Indian drugmakers likely to gain under the new US government

Industry experts are hopeful of India's trajectory as the US is facing shortages and backorders. They said with many blockbuster drugs were going off-patent between 2025 and 2029. "The Indian pharma industry will have a further growth opportunity in the form of generics."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tgOescK
via IFTTT